scholarly journals Body composition profile of children and adolescent patients with inflammatory bowel disease

Author(s):  
Hadeel A. Alsufyani ◽  
Mahmoud M. Mosli ◽  
Omar I. Saadah
2021 ◽  
Vol 14 ◽  
pp. 175628482098667
Author(s):  
Kata Judit Szántó ◽  
Tamás Balázs ◽  
Dóra Mihonné Schrempf ◽  
Klaudia Farkas ◽  
Tamás Molnár

Background: There is a lack of data about demographic and treatment characteristics of adolescent patients with inflammatory bowel disease (IBD). The aim of this retrospective, epidemiological study was to evaluate characteristics and therapeutic features of Hungarian adolescents with IBD. Methods: We analysed the social security databases of the National Health Insurance Fund. Adolescent patients with IBD for whom data from 2009 to 2016 were observable in the database were enrolled. Patients aged 14 to 17 years and 18 to 21 years were defined as middle and late adolescent patients. Results: The incidences of IBD were 20.12 per 100,000 middle adolescent patients and 29.72 per 100,000 late adolescent patients. Admission to gastroenterology department was higher in both groups compared with admissions to surgery department. Mesalazine was used by a high proportion of Crohn’s disease and ulcerative colitis patients. Rates of corticosteroid use were similar in both groups, with a tendency to decrease over time. The need for biologic agents was higher in the middle adolescent patients. The proportion of patients in the middle adolescent group who received anti-TNF therapy showed an increasing tendency. Conclusion: Our data suggest differences in the treatment strategies of gastroenterologists for these age groups. The greater need of anti-TNF therapy among the middle adolescent group indicates that adolescent patients before the transition to adult care may have a more severe disease phenotype. We expect that a strategy of early, effective treatment will significantly ameliorate the subsequent disease course, which is manifested in adult care.


2020 ◽  
Vol 179 (10) ◽  
pp. 1499-1505
Author(s):  
Saurabh Talathi ◽  
Pooja Nagaraj ◽  
Traci Jester ◽  
Jeanine Maclin ◽  
Taylor Knight ◽  
...  

2016 ◽  
Vol 52 (5) ◽  
pp. 547-555 ◽  
Author(s):  
Céline Callias ◽  
Jessica Ezri ◽  
Pedro Manuel Marques-Vidal ◽  
Andreas Nydegger

2008 ◽  
Vol 101 (5) ◽  
pp. 676-679 ◽  
Author(s):  
Raquel Rocha ◽  
Genoile Oliveira Santana ◽  
Neogélia Almeida ◽  
Andre Castro Lyra

Inflammatory bowel disease (IBD) is often associated with malnutrition. The aim of this study was to compare the body composition of outpatients with IBD during remission and active phase. In order to evaluate disease activity we used Crohn's Disease Activity Index for Crohn's disease (CD) patients and Lichtiger's Index for ulcerative colitis (UC) patients. All patients underwent the analysis of BMI, arm muscle area (AMA) and triceps plus subscapula skinfold thickness (TST+SST) to identify total, muscle and fat mass, respectively. In total 102 patients were evaluated (CD,n50; UC,n52) and the majority was young women. Malnutrition according to BMI was found in 14·0 % of patients with CD and 5·7 % of UC patients. Muscle mass depletion was detected in more than half of the CD and UC patients. The BMI, TST+SST and AMA values were lower in the active phase only in CD patients (P < 0·05). Fat mass depletion was associated with active phase in both CD and UC patients. Body composition parameters obtained using BMI, TST+SST and AMA were not correlated with the presence of fistula in CD patients (P>0·05). In conclusion, patients without signs of malnutrition had fat mass depletion especially in the active phase and muscle mass depletion occurred both in CD and UC patients.


Author(s):  
Edgars Bodnieks ◽  
Aldis Puķītis ◽  
Juris Pokrotnieks

Abstract Nutrition has an important role in the management of inflammatory bowel disease (IBD) and metabolic syndrome (MS). The goal of this study was to assess the nutritive status of patients treated with IBD and metabolic syndrome in the Gastroenterology Centre, Pauls Stradiòð Clinical University Hospital. Body bioelectrical impedance analysis (BIA) using GENIUS 220 PLUS (Jawon Medical) was used to determine Body Mass Index (BMI) kg/m², Metabolic Body Fat (MBF) kg, Soft Lean Mass (SLM) kg, Total Body Water (TBW) kg, body composition, metabolic type, Basal Metabolic Rate (BMR) kcal, and total Energy Expenditure (TEE) kcal in patients with IBD and metabolic syndrome and in a similarly aged control group. The obtained data showed that BMI was not correlated with MBF, BTW and Lean Body Mass (LBM). Patients with Crohn’s disease (CD) had normal value of BMI (M 24.3 kg/m²; F 20.2kg/m²), but we found variety-specific differences in body composition that confirmed deficiency or increase of specific body parameters. The performed prospective study confirmed the importance of the more precise nutritional status analysis, as it was clinically useful for the nutritional management of IBD. Patients with CD had expressed nutrient deficiency, sarcopenia, and reduced amount of proteins and minerals. For patients with MS, sarcopenia was present despite obesity.


2010 ◽  
Vol 19 (1) ◽  
pp. 80-88 ◽  
Author(s):  
Kevin A. Hommel ◽  
Shannon Odell ◽  
Emily Sander ◽  
Robert N. Baldassano ◽  
Frances K. Barg

Sign in / Sign up

Export Citation Format

Share Document